DOYLE MITTIE (Chief Medical Officer) sold 2.7% of their position (1.45K shares) of AVALO THERAPEUTICS, INC. on the open market
Open‑market sale worth $26.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/25/2026ACC: 0001918845-26-000020
Officer· Chief Medical Officer
Since Feb 2026
-1.45K
Net shares
Net seller
$26.1K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
1.45K acquired · 2.90K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1.45K
Price / share
$8.04
Trade value
$11.66K
% of position
2.8%
6/23/2026
51.78K→53.23K
Common Stock
Direct
Shares
−1.45K
Price / share
$18.00
Trade value
$26.10K
% of position
2.7%
6/23/2026
53.23K→51.78K
Total
Net shares
+0.00
Net value
-$14.44K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/23/2026 | M · Option Exercise | +1.45K | $8.04 | $11.66K | 2.8% | 51.78K | 53.23K |
| Common Stock Direct | 6/23/2026 | S · Sale | −1.45K | $18.00 | $26.10K | 2.7% | 53.23K | 51.78K |
| Total | +0.00 | -$14.44K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
1.45K shares
Shares
−1.45K
Strike price
8.04
Held after
116.87K
Exercisable
—
6/23/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock1.45K shares | 6/23/2026 | M · Option Exercise | −1.45K | 8.04 | — | 116.87K |